文献

J-GLOBAL ID：201902223859186737   整理番号：19A0694246

臨床環境における114癌関連遺伝子のパネル試験の実現可能性と有用性:病院ベース研究

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study

著者 (46件)： Sunami Kuniko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Ichikawa Hitoshi (Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan) ,  Ichikawa Hitoshi (Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan) ,  Kubo Takashi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Kubo Takashi (Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan) ,  Kubo Takashi (Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan) ,  Kato Mamoru (Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan) ,  Fujiwara Yutaka (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Shimomura Akihiko (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Koyama Takafumi (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Kakishima Hiroki (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Kitami Mayuko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Matsushita Hiromichi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Furukawa Eisaku (Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan) ,  Narushima Daichi (Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan) ,  Nagai Momoko (Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan) ,  Taniguchi Hirokazu (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Motoi Noriko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Sekine Shigeki (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Maeshima Akiko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Mori Taisuke (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Watanabe Reiko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Yoshida Masayuki (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Yoshida Akihiko (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Yoshida Hiroshi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Satomi Kaishi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Sukeda Aoi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Hashimoto Taiki (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Shimizu Toshio (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Iwasa Satoru (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Yonemori Kan (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Kato Ken (Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Morizane Chigusa (Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Ogawa Chitose (Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Tanabe Noriko (Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan) ,  Sugano Kokichi (Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan) ,  Sugano Kokichi (Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Tochigi, Japan) ,  Hiraoka Nobuyoshi (Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan) ,  Tamura Kenji (Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Yoshida Teruhiko (Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan) ,  Fujiwara Yasuhiro (Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Fujiwara Yasuhiro (Strategic Planning Bureau, National Cancer Center, Tokyo, Japan) ,  Ochiai Atsushi (Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan) ,  Yamamoto Noboru (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan) ,  Kohno Takashi (Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan) ,  Kohno Takashi (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 110  号： 4  ページ： 1480-1490  発行年： 2019年 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 腫瘍組織の次世代配列決定(NGS)(すなわち臨床シークエンシ...

シソーラス用語： ヌクレオチド配列 ,...
準シソーラス用語： 次世代シークエンシング ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0694246&from=J-GLOBAL&jstjournalNo=U0505A") }}

著者キーワード (5件)： 活性化可能な遺伝子異常 ,  臨床シークエンシング ,  遺伝子パネル試験 ,  保険再構築 ,  NCC Oncopanel

分類 (1件)： 臨床腫よう学一般  (GE03010Y)

タイトルに関連する用語 (7件)： 臨床 ,  環境 ,  試験 ,  実現可能性 ,  有用性 ,  病院 ,  研究